CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 123 filers reported holding CYTOKINETICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $216,000 | +14.3% | 18,300 | +2.9% | 0.01% | +16.7% |
| Q4 2019 | $189,000 | -4.1% | 17,790 | +3.0% | 0.01% | -25.0% |
| Q3 2019 | $197,000 | +1.5% | 17,270 | 0.0% | 0.01% | -42.9% |
| Q2 2019 | $194,000 | +49.2% | 17,270 | +7.7% | 0.01% | +55.6% |
| Q1 2019 | $130,000 | +32.7% | 16,040 | +3.0% | 0.01% | +50.0% |
| Q4 2018 | $98,000 | -17.6% | 15,570 | +8.4% | 0.01% | 0.0% |
| Q2 2018 | $119,000 | -13.1% | 14,360 | -24.4% | 0.01% | -14.3% |
| Q1 2018 | $137,000 | -11.6% | 18,990 | 0.0% | 0.01% | -12.5% |
| Q4 2017 | $155,000 | -43.6% | 18,990 | 0.0% | 0.01% | -46.7% |
| Q3 2017 | $275,000 | +108.3% | 18,990 | +74.7% | 0.02% | +114.3% |
| Q2 2017 | $132,000 | – | 10,870 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |